Name: Phenylpiracetam Powder &amp; Capsules
SKU: 6527
Availability: InStock
Rating: 4.63 (78 reviews)

thirdpartysafety

Phenylpiracetam is a nootropic compound in the racetams group.

Phenylpiracetam (2-(2-Oxo-4-phenylpyrrolidin-1-yl)acetamide) is a derivative of Piracetam (ref)*
Synthesized in 1983 (ref), it is fat soluble and provides superior absorption (ref)*
More potent than Piracetam (ref)*
Assured Purity: Rigorously tested for quality & purity by third-party Certificate of Analysis*

Phenylpiracetam Chemical Properties

Phenylpiracetam’s molecular formula is C₁₂H₁₄N₂O₂ and it has a molar mass of 218.106 g/mol.

The CAS Number is 77472-70-9 (6).

The bioavailability is near 100% (4). Phenylpiracetam is eliminated through excretion of 40% in urine, 60% in bile and perspiration (2), and its’ half-life is 3-5 hours (2).

Phenylpiracetam Capsules and Powder

Pure Nootropics’ offers Phenylpiracetam in 100 mg capsules (bulk powder options are also available).

Phenylpiracetam Toxicity

The LD50 dose was achieved in a mouse at a dose of 6800 mg/kg (5), many times higher than normal doses.

For further information, please see our References Tab above.

Additional Information

Weight	N/A
Dimensions	N/A
Quantity	7.5g, 15g, 30 x 100mg Capsules, 90 x 100mg Capsules

PHENYLPIRACETAM CERTIFICATE OF ANALYSIS 10/2019

PHENYLPIRACETAM CERTIFICATE OF ANALYSIS 02/2019

PHENYLPIRACETAM CERTIFICATE OF ANALYSIS 12/2018

PHENYLPIRACETAM CERTIFICATE OF ANALYSIS 04/2018

The references below are not meant to imply that any of our products treat, cure, or diagnose any disease or human condition. This product is sold as a research chemical and is for research purposes only; we recommend consulting a professional about how to handle this chemical. References to clinical studies and pre-clinical studies may use varying dosages and may not represent the dosages or subsequent results of products we sell; however, the references provided are pertinent to the subject supplement itself. References provided are intended for research and informational purposes only and do not represent the entire body of knowledge available on the subject(s) referenced; nor do they represent all possible outcomes associated with the subject(s) referenced including, but not limited to, adverse effects, precautions, or chemical interactions within the human body. The Content provided on this website is not intended to be a replacement for professional medical advice, treatment or diagnosis. Never ignore the advice of a medical professional or delay in attaining professional advice because of information or impressions you gather on this website. Choosing to rely on any information provided by the Content of this website is solely at your own risk. We encourage our audience to do their own research beyond the resources we have provided so your decision is as educated as possible.

1. “Phenylpiracetam,” Examine.com, published on 29 September 2013, last updated on 2 October 2018, https://examine.com/supplements/phenylpiracetam/.
2. Wikipedia contributors. “Phenylpiracetam.” Wikipedia, The Free Encyclopedia. Wikipedia, The Free Encyclopedia, 7 Feb. 2019. Web. 27 Feb. 2019.
3. Malykh, AG, and MR Sadaie. “Piracetam and Piracetam-like Drugs: from Basic Science to Novel Clinical Applications to CNS Disorders.” Drugs, vol. 70, no. 3, 12 Feb. 2010, pp. 287–312., doi: 10.2165/11319230-000000000-00000. https://www.ncbi.nlm.nih.gov/pubmed/20166767.
4. “Pharmaceutical Composition Eliciting Nootropic Activity and Method for Its Preparing.” Google Patents, patents.google.com/patent/RU2240783C1/en.
5. “Safety Data Sheet Phenylpiracetam.” Cayman Chemicals, 5 Dec. 2013, www.caymanchem.com/msdss/13897m.pdf.
6. “Phenylpiracetam.” PubChem Open Chemistry Database, pubchem.ncbi.nlm.nih.gov/compound/phenylpiracetam#section=Top.